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Abstract
Cause of death differentiation during a medicolegal autopsy can be complicated by several
factors, including sample conditions which can create uncertainty. Postmortem protein analysis
has potential to be used as an additional evidentiary tool in determining cause of death.
Proteomic biomarkers offer a method to directly measure physiological conditions at time of
death that are stable in a postmortem state. Specific protein expression levels have been studied
for their postmortem application in significantly differentiating many different causes of death.
Work done in regard to asphyxial, toxicological, and traumatic deaths will be specifically
discussed here. Proteins will be reviewed for potential diagnostic efficacy through specificity,
sensitivity, and detailed thresholds with attention to the research conditions. While significant
trends have been recognized, further work is required to validate potential applications in
forensic pathology. For many biomarkers, significant correlation to cause of death, the agonal
period, or the influence of a postmortem state is still being determined. The use of one protein by
itself has not yet been able to differentiate cause of death with high enough specificity and
sensitivity. Therefore, the use of a panel of validated biomarkers is suggested to increase
significance in diagnostic efficacy.

Keywords: forensic science, forensic pathology, biomarker, medicolegal autopsy, proteomics,
cause of death

Introduction
The field of proteomics is vital to understanding physiological responses through
studying protein expression. Proteins are translated from the messenger RNA (mRNA), which is
transcribed from the genome in response to specific stimuli. Due to this predictable and
measurable biological response, protein expression can be used to elucidate physiological
processes that are occurring. Biomarkers, often proteins, are quantifiable indicators of standard
and novel physiological activity. Biomarkers can be utilized to track the progression of diseases,
evaluate health risks, and act as diagnostic tools. Diagnostic biomarkers are identified by the
quantification of situation-specific markers in conditions of interest (Califf 2018). There is great
importance in the validation of methodologies and thresholds when considering the efficacy of
biomarkers, as well as the determination of which biomarkers are reliable under what
circumstances. The identification of reliable biomarkers and appropriate thresholds must be
strictly established to prevent misdiagnoses. For example, Alpha-2-HS-glycoprotein (AHSG) has
been found to remain stable in bone after death and decline with age. Due to the postmortem
stability of AHSG, it has been considered as a potential indicator of biological age. AHSG was
validated as a reliable indicator through ascertaining the relationship between the standard
abundance of proteins within bone and biological ages to determine age-specific threshold levels
(Duong et al. 2021). After determining the reliability of this potential biomarker, levels of AHSG
can now be used as a biomarker when determining age at time of death.
Bottom-up approaches are commonly used in determining proteomic profiles. Samples in
which proteins have been first digested are often easier to analyze through liquid
chromatography-tandem mass spectrometry (LC-MS/MS). While a top-down approach allows
for the identification of proteoforms, it faces difficulties in the separation and quantification of

proteins (Duong et al. 2021). LC-MS/MS is a popular technique due to its high specificity and
ability to provide rapid results. Enzyme-linked immunosorbent assay (ELISA) is another favored
technique that allows for the identification and quantification of proteins, as well as other
substances, at a high level of specificity. Immunohistochemistry (IHC) analysis is a wellestablished method for locating proteins within tissues. IHC analysis can provide locationspecific information but is less specific than the previously mentioned methodologies (Duraiyan
et al. 2012).
The field of forensic science works to provide scientific analysis of evidence that can be
used in a legal application. Analytical work, such as DNA analysis and toxicology, is often
conducted. DNA analysis is a powerful tool in the identification of human samples but faces
limitations in assessing the type of sample and cause of death. DNA is additionally subject to
degradation whereas most proteins are fairly stable. Forensic pathology often utilizes
medicolegal autopsies to reveal the determinants of death through gross anatomy, tissue, and
body fluid examinations. The conduction of autopsies and their conclusive findings face issues
related to the condition of the sample and the level of decomposition. Examining biomarkers
through a proteomic perspective as a method of forensic pathology could aid in understanding
the body’s response to the cause of death through evidence-based practices. Proteomic methods
have already been used under a forensic perspective by identifying tissues and drugs and
determining postmortem intervals (PMI) (Duong et al. 2021).
There is currently a need for additional investigative methods in cases where the cause
and manner of death are difficult to reveal within forensic pathology. A proteomic perspective
could provide supplemental pieces of evidence at an additional level of specificity. The
evaluation of biomarkers from a forensic perspective is crucial due to their potential diagnostic

efficacy. There is currently a lack of a cohesive review on biomarkers that hold potential
diagnostic efficacy as determinants of causes of death. This paper will review protein biomarker
studies on deaths that would fall under suspicious circumstances and forensic jurisdiction. This
will be inclusive of asphyxial, toxicological, and traumatic deaths. This paper will do the work of
reviewing studies done on postmortem protein expression as a means of finding significant
biomarkers linked to specific causes of death. Unreliable biomarkers will be discussed with
attention to the requirement for the validation of methodologies and strict thresholds. By
reviewing and unifying work done on protein analysis under different circumstances of death, it
will be possible to begin creating a collective source of potential biomarkers that could be
reliably used as diagnostic tools for specific causes of death.
Asphyxiation
Fatal asphyxiation occurs when the body dies during an extended hypoxic state.
Deprivation of oxygen can occur in multiple ways which can uniquely determine the body’s
physiological response during the induced widespread hypoxic state. The classification of
asphyxial death is under debate and requires standardization. This paper will refer to the
classification of four main types: suffocation, strangulation, mechanical asphyxia, and drowning.
Sauvageau and Boghossian (2010) characterized suffocation as a deprivation of oxygen due to
external influences. Deaths due to smothering, vitiated atmospheres, and choking are subtypes of
suffocation. Strangulation is defined by physical obstruction of airways and includes subtypes of
ligature and manual strangulations, as well as hangings. Mechanical asphyxia refers to the
inability of oxygen to access the respiratory system due to the physical position of the body.
Mechanical asphyxia encompasses positional and traumatic asphyxia. Drowning is distinguished
by immersion in a liquid. Throughout the literature on asphyxia, it is common to refer to

strangulation as mechanical asphyxia; this paper will classify physical obstructions as
strangulation.
Due to the extensive spread of asphyxial deaths, there is a lack of standardized responses
that can be reliably reported. There is no postmortem test in determining asphyxial deaths,
therefore, medicolegal autopsies rely on a variety of physical markers, internal examinations, and
biological sample analyses under many different circumstances. The classical signs of
asphyxiation include petechiae, congestion and edema, cyanosis, and fluidity of blood (Saukko,
2015, p. 354-358). While these findings are commonly associated with asphyxiation, they are
nonspecific due to their association with other causes of death. These signs are additionally not
guaranteed to be observable in each case of asphyxiation. For example, hyoid fractures may be
observed in some cases of strangulation but are unlikely to be observed in suffocation. Because
of the lack of exclusively linked markers in determining asphyxial deaths, proteomic profiles
provide a viable option for specific determination.
S100
S-100 is a calcium-binding protein with an A and B subunit that is one possible
biomarker candidate for asphyxiation. The subunit S100B is strongly associated with the central
nervous system and has been investigated as a marker of brain tissue damage (Li et al. 2010).
S100B is strongly expressed in astrocytes, which are abundant glial cells within the brain
(Sofroniew and Vinters 2010). While elevated levels of serum S100B may be associated with
brain tissue damage, these findings have been observed in causes of death without head injury
(Li et al. 2010). Because elevated serum levels of S100B are nonspecific to head trauma, it might
serve as a marker of hypoxic brain damage that can occur during asphyxia. This relationship
offers the potential of using S100 protein as a biomarker of asphyxiation.

Evaluation of postmortem S100 levels through immunohistostaining astrocytes and
quantifying serum levels revealed that, typically, S100-positivity in astrocyte and serum levels
display an inverse relationship (Li et al. 2006). Half of the studied drowning cases did not follow
this pattern and displayed low S100-positivity in astrocytes and decreased levels of S100B in
serum (Li et al. 2006). High S100-positivity has been observed in cases of strangulation and low
S100-positivity in astrocytes in cases of suffocation (Li et al. 2006). Elevated S100B in serum
from right heart blood has been observed in cases of suffocation and low levels in strangulation
(Li et al. 2006). Cerebral spinal fluid serum levels of S100B are elevated in cases of
strangulation and decreased in cases of drowning (Li et al. 2009). Immunostaining astrocytes
within the hippocampus showed low S100-positivity in cases of strangulation (Li et al. 2010).
The evaluation of S100 as a biomarker shows the most significance for being a determinant of
strangulation. Studies have consistently linked elevated serum levels of S100B, in whole blood
and cerebral spinal fluid, and low S100-positivity in astrocytes, from the cerebrum and
hippocampus, to cases of strangulation. Cases of suffocation show similar potential but do not
have the same amount of validation studies. The relationship between S100 and drowning
requires further research as well as mechanical asphyxia which was not included in any studies.
Special attention is additionally required for cases in which head injuries and asphyxia overlap
which has not been previously studied and could produce misleading results.
Pulmonary Surfactant-Associated Proteins
Pulmonary surfactant-associated proteins are involved with the lung's immune response,
pathogen interactions, and lowering surface tension. Pulmonary surfactant proteins A (SP-A) and
D (SP-D) are localized to the lungs and are responsible for coordinating immune responses and
pulmonary host defense mechanisms (Han and Mallampalli 2015). SP-A and SP-D have direct

ties to the health of the lung and their serum levels can be measured in evaluating the lung’s
pathological response to disease (Takahashi et al. 2006). Damage to alveolar septa can cause
pulmonary surfactant-associated proteins to leak into blood serum. This relationship between
pulmonary surfactant-associated proteins and lung health, alongside accessibility of this protein,
offers potential as a biomarker of asphyxiation.
Evaluating intra-alveolar aggregates of SP-A has provided conflicting results. A study
conducted on 53 cadavers found an increase in intra-alveolar aggregates of SP-A in cases of
freshwater drowning (Zhu et al. 2002). Lee et al. (2017) found that the increase of SP-A granular
deposits is significant to drowning irrespective of water type from sampling 10 rats. Further
studies are needed to validate a consistently higher SP-A score in freshwater drownings, but
there is a significant overall increase in intra-alveolar aggregates of SP-A in lung tissue in cases
of drowning not observed in other cases of death.
Serum levels of SP-A have been observed to be standard values in cases of suffocation
and strangulation (Ishida et al. 2000). From a pool of 6 cadavers, all of the saltwater drownings
were found to display a significant increase in sera SP-A while 33% of freshwater drownings
were found to display an increase (Ishida et al. 2000). More studies are required to elaborate on
this relationship and to determine significant trends. Quan et al. (2009) researched 59 cadavers
and found consistently elevated levels of serum SP-A and SP-D in deaths due to drowning but
did not specify findings respective to water type. Further studies on serum SP-D confirmed
elevated levels in cases of strangulation and drowning while noting increased levels in saltwater
drownings compared to freshwater (Kamada, Seo, and Takahama 2000). Consistently studies
have found an increase in levels of sera SP-A and SP-D in cases of drowning and these hold the
most potential as possible biomarkers of drowning.

As levels of serum SP-A reflect alveolar injury more than asphyxiation, there is one
unresearched subtype of asphyxiation where there is a potential use for serum SP-A as a reliable
biomarker (Maeda et al. 2003). Serum SP-A will leak from the lungs to the general blood serum
in the event alveolar septa are damaged, it is theorized that lethal compression of the chest,
especially in cases of mechanical asphyxiation, could cause damage and potential elevation of
serum SP-A. The transcriptomes of SP-A have been further studied to determine differences in
expression between SP-A1 and SP-A2 (Ishida, Zhu, and Maeda 2000). The ratio of mRNA SPA1/SP-A2 was found to be higher in cases of asphyxiation and drowning, however, the sample
of asphyxial deaths was inclusive of strangulation, suffocation, and mechanical asphyxiation
(Ishida, Zhu, and Maeda 2000). Evaluation of potentially significant differences in sera SP-A1
and SP-A2 across the subtypes of asphyxiation is necessary for the qualification of a reliable
biomarker. Additionally, due to the secretion of SP-A in response to forceful breathing, it is
theorized that increases in intra-alveolar aggregates could be a reliable marker for cases of fatal
drowning compared to postmortem immersion (Stemberga 2009).
Albumin and Globulin
Albumin and globulin are two major plasma proteins within the blood serum. Albumin is
synthesized by the liver, freely circulating, and aids in maintaining oncotic pressure as well as
hormone and drug transport. Albumin has not been extensively researched as a biomarker for
differing causes of death but there is potential. Blood serum proteins have been found to remain
stable postmortem and in stored blood (Quan et al. 2009). In evaluating albumin levels in
relation to cause of death, 23 cases of strangulation reported significant elevation from cardiac
samples (Quan et al. 2009). Freshwater drownings have displayed decreased levels of vitreous
albumin compared to postmortem immersion in a study done on 12 rabbits (Agoro, Chinyere,

and Akubogwo 2020). Elevated levels of vitreous IgG and IgM were observed in deaths due to
freshwater drowning when compared to postmortem immersion (Agoro, Chinyere, and
Akubogwo 2020).
While the decrease in the ratio of albumin/globulin shows potential as a signal of deaths
due to drowning when compared to postmortem immersion in a freshwater medium, further
studies are necessary. The increase in globulin proteins is likely due to the body’s immune
response and is not significant to drowning (Agoro, Chinyere, and Akubogwo 2020). Elevated
levels of globulin proteins have also been reported in cases of suffocation, specifically CO
intoxication (Agoro, Chinyere, and Akubogwo 2020). These findings came from one study done
on 12 rabbits, drowned only in freshwater, and compared to euthanized control deaths (Agoro,
Chinyere, and Akubogwo 2020). The validation and creation of thresholds done in human
studies are required for plasma proteins to be used as a biomarker. Additionally, research done
on the relationship between the cause of death and plasma proteins has neglected to differentiate
between water types in drownings. Albumin has a high chance of being an indicator of
freshwater drowning due to its hypotonic nature. Biochemistry of freshwater drownings can be
associated with a decrease in plasma concentrations of sodium, chloride, calcium, and albumin
(Agoro, Ikimi, and Edidiong 2021). These changes in concentrations offer another potential
piece of evidence for diagnostic criteria but thresholds still need to be validated.
Thyroglobulin
Thyroglobulin (Tg) is a glycoprotein produced by thyroid follicular cells. Tg functions in
synthesizing the thyroid hormones thyroxine (T4) and triiodothyronine (T3). In evaluating tumor
recurrence in thyroid cancer, serum Tg levels are used as diagnostic biomarkers (Indrasena
2017). Serum Tg levels are qualifiable as a biomarker because overexpression of circulating Tg

is indicative of an overactive or carcinogenic thyroid gland. External damage to the thyroid gland
is theorized to display a similar pattern. This theory has led to Tg being researched as a
diagnostic biomarker for cases of lethal neck compression due to induced damage to the thyroid
gland.
Enzyme-linked immunosorbent assay of serum thyroglobulin in cases of death with and
without external neck compression found serum Tg levels to be significantly elevated in right
heart blood (RHB) samples compared to left heart blood (LHB) samples (Tamaki and Katsumata
1989). Elevated levels of Tg were not strongly correlated with strangulation as deaths unrelated
to fatal neck compression have been observed to have elevated levels of Tg from RHB samples
(Tamaki and Katsumata 1989). Deaths due to strangulation and choking, a subtype of
suffocation, displayed elevated levels of Tg in cardiac blood samples alongside deaths due to
cranial trauma (Muller, Franke, and Koch 1997). Muller, Franke, and Koch (1997) thought
elevated Tg levels to be correlated with the duration of the agonal period, allowing more time for
pathway activity to produce more Tg, instead of damage to the thyroid gland itself. An extended
agonal period as well as potential damage to the hypothalamus, which stimulates thyroidreleasing hormone and is at the beginning of the thyroid cascade, is not significant to
asphyxiation and it is important to not use these factors as sole determinants.
As elevated levels of Tg have been observed in multiple causes of death, especially in
right heart blood samples, it is important to understand the influence of postmortem changes.
RHB samples are probable to display increased levels of Tg due to physical proximity
(Hayakawa et al. 2014). The venous circulatory system is also likely to have increased levels of
Tg due to the amount of retained blood after death (Hayakawa et al. 2015). Because RHB and
iliac venous blood (IVB) Tg levels are influenced by postmortem changes, they are not reliable

locations to sample from. Iliac arterial blood (IAB) is thought to be the most reliable location due
to its independence from postmortem changes and will reflect actual physiological processes
after death (Hayakawa et al. 2015). In considering the potential reliability of biomarkers, it is
crucial to consider the impact of postmortem changes and sample sources. Tg persists in being a
complicated biomarker with its susceptibility to elevation postmortem. Hayakawa et al. (2014)
suggest levels of Tg below the standard value of 200ng/mL in both RHB and LHB being
significant for no neck compression. Hayakawa et al. (2015) suggest comparing RHB, LHB,
IVB, and IAB, and if there are small differences, <100ng/mL, between Tg levels and if the level
of Tg in the IAB sample is below the standard value, there is the most significance in
determining these values have not yet been affected by postmortem changes and there was no
neck compression significant enough to cause thyroid damage. With these criteria for
significance created, future studies to validate the reliability of this biomarker are necessary for it
to be used in practice.
Cultured cell experiments used to study the relationship between thyroid-related
hormones and hypoxia have suggested that T3, T4, and Tg are elevated in hypoxic situations
independent of TSH control (Tani et al. 2020). This factor could lend to the possibility of Tg as a
reliable marker for hypoxic conditions, but this is nonspecific to asphyxial conditions. Palmiere
et al. (2018) confirmed the stability of Tg and related thyroid hormones as well as their increase
in expression in cases of strangulation. While Tg itself may be an unreliable marker, there is
potential in investigating thyroid hormones in relation to strangulation.
Aquaporins
Aquaporins are membrane-bound proteins found throughout the body that function in the
transfer of water and occasionally glycerol transport. Aquaporins can broadly function in the

maintenance of osmotic gradients and are integral to typical physiological activity in the lungs,
kidneys, and epidermis (Yadav et al. 2020). Aquaporin 3 (AQP3) functions in epidermal
keratinocytes and transfers glycerol and water. In studying AQP3 expression as a marker of
vitality in skin injuries, it was found that AQP3 expression was significantly elevated across all
types of physical trauma and aquaporin 1 expression levels are nonsignificant (Prangenberg et al.
2021). This relationship between AQP3 expression and skin injuries can be considered as a
potential marker for asphyxial deaths related to strangulation due to external trauma to the neck.
Ishida et al. (2018) studied 56 cases of strangulation through immunostaining AQP3 and found
expression levels to be significantly elevated in all cases of strangulation. These results were
found to be independent of postmortem changes, age, and gender of the deceased, aquaporin 1
was found to be nonsignificant (Ishida et al. 2018). AQP3 stands to be a reliable indicator for
mechanical skin compression and could be a helpful tool in determining cases of strangulation.
However, AQP3 expression has not been studied across other cases of asphyxial deaths and it is
recommended against using AQP3 expression as a sole biomarker.
Aquaporin 5 (AQP5) is found within lung tissue and is water permeable. A study done
across 64 cases of death spanning from strangulation to suffocation and controls of sudden
cardiac death and acute brain injury found cases of strangulation to have elevated expression of
AQP5 (Wang et al. 2012). AQP5 expression was additionally found to be significantly
suppressed in cases of suffocation (Wang et al. 2012). Aquaporin 1 was additionally found to
have no significantly different expression levels (Wang et al. 2012). This dichotomy between
expression levels suggests AQP5 is a reliable marker between suffocation and strangulation
deaths. A rat study found increased expression of AQP5 and receptor for advanced glycation end
products (RAGE) in drowned groups compared to postmortem immersion (Lee et al. 2019).

AQP5 expression was additionally higher in saltwater drownings when compared to freshwater
drownings (Lee et al. 2019). Research of AQP5 expression in differentiating between water
mediums has been continued in human subjects with conflicting results. A study done across 28
lung samples found there to be an increase in AQP5 expression in saltwater drownings, while a
study of 30 lung tissue samples found there to be no significant difference between water
mediums (Prangenberg, Doberentz, and Madea 2021). While AQP5 expression appears
significant for drownings, it is inconclusive if AQP5 is a reliable biomarker in differentiating
water mediums.
In an attempt to differentiate between water mediums in deaths due to drowning,
aquaporin 2 (AQP2) and aquaporin 4 (AQP4) have been considered. AQP2 is expressed in renal
tissue and is shown to have increased expression levels in saltwater drownings (Prangenberg,
Doberentz, and Madea 2021). AQP4 expression within the brain and shown to be significantly
elevated in freshwater drownings and significantly lower in saltwater drownings when compared
to control groups (Prangenberg, Doberentz, and Madea 2021). The use of AQP2 and AQP4
together shows promise as a differentiating tool in water mediums, while the use of AQP5 is just
significant for drownings in general. This highlights the importance of this paper’s proposal in
the use of a panel of biomarkers in gaining more evidence in medicolegal autopsies.
Hypoxia-Inducible Factor 1
Under hypoxic conditions, hypoxia-inducible factor 1 (HIF1) is activated and induces
erythropoietin (EPO) transcription in liver cells, which stimulates erythropoiesis (Wang and
Semenza 1993). Quan et al. (2009) reported that in asphyxial deaths, red blood cell count was
elevated compared to blunt injury deaths. HIF1 additionally regulates vascular endothelial
growth factor (VEGF) which is involved with metabolic adaptations to hypoxic conditions (Zhao

et al. 2006). Elevated levels of hypoxia-inducible factor 1 alpha (HIF1-α), a subunit of HIF1,
have been observed in asphyxial deaths from lung tissue samples (Cecchi et al. 2013). HIF1-α
was reported to be sensitive to putrefaction and most significantly elevated in cases of
strangulation and suffocation, while cases of drowning were not strongly correlated (Cecchi et al.
2013). Cecchi et al. (2013) studied the expression of P-selectin and E-selectin alongside HIF1-α
and found they expressed no reliable significance between causes of death. In studying the
mRNA expression of HIF1-α, EPO, and VEGF in renal tissue cases of drowning displayed low
levels of expression for all three (Zhao et al. 2006). Cases of strangulation and suffocation were
observed to have elevated levels of HIF1-α and EPO, while VEGF expression was low in cases
of strangulation but elevated in cases of suffocation, specifically aspiration (Zhao et al. 2006).
HIF1-α expressivity holds the potential to differentiate between cases of drowning to other
asphyxial deaths, excluding the unstudied category of mechanical asphyxiation. However, HIF1α expression does not differentiate between suffocation and strangulation where VEGF suggests
to.
Atrial and Brain Natriuretic Peptides
In the event of drowning, the hypotonic nature of freshwater can increase blood volume
and decrease electrochemical gradients and dilute plasma proteins, while environments with
saltwater would cause an opposite effect. Atrial natriuretic peptide is secreted in response to
increased blood pressure and volume at the heart and is theorized to be a significant sign of
drowning. A study done on 50 rabbits found elevated levels of atrial natriuretic peptide in cases
of drowning compared to postmortem immersion, through sampling sera and both atria (Lorente
et al. 1990). Atrial samples showed no significant differences between the study groups, due to
the stored nature of peptides there, while plasmic levels within the freshwater group displayed

significantly elevated levels (Lorente et al. 1990). Atrial and brain natriuretic peptides have been
observed to display significantly lower expression levels in cases of drowning and strangulation
when compared to sudden cardiac deaths through mRNA expression within the ventricles (Chen
et al. 2012). Expression levels of atrial and brain natriuretic peptides were not significant
between water mediums in cases of drownings (Chen et al. 2012). While the mRNA expression
of atrial and brain natriuretic peptides is observed to differentiate between causes of death, it is
reported that the immunostaining of these peptides has been inconclusive (Chen et al. 2012).
Atrial and brain natriuretic peptides hold potential as a determinant for drowning, however, it is
increasingly important to recognize the significance of sampling sites. It is additionally important
to validate the significance of the relationship between protein levels and the cause of death in
human studies.
Other Possible Biomarkers of Asphyxiation
Few other proteins have been looked at in extensive detail but show promise as
biomarkers. Cytochrome C (Cyto c) and apoptosis-inducing factor (AIF) are expelled from
mitochondria under hypoxic conditions. Zhang et al. (2019) found elevated levels of Cyto c and
AIF in 8 samples of myocardial and brain tissue in deaths due to strangulation. Cyto c and AIF
show promise as a signal for strangulation but still need to be vastly studied in humans and
across additional causes of death. Hernández-Romero et al. (2020) found apolipoprotein A1 and
α-1 antitrypsin to be potential biomarkers for deaths due to drowning. Cases of drowning when
compared to strangulation and traumatic deaths were observed to have significantly elevated
levels of serum apolipoprotein A1 and decreased levels of α-1 antitrypsin (Hernández-Romero et
al. 2020). ER stress-related protein CHOP, sampled from brain tissue, was additionally recently
identified as a potential biomarker for deaths due to strangulation (Hu et al. 2021). While both of

these studies offer promising results, they both have small sample sizes of less than 20 and
require further validation before they are able to be used.
Gene expression profiling conducted on mouse lung tissue in response to strangulation
showed increased activity of three mRNA transcripts for genes dual specificity phosphatase
1(Dusp-1), domain family protein 3 (TSC22d3), and Luc7 homolog (Saccharomyces cerevisiae)like (Luc7l) (Takahashi et al. 2009). Dusp-1 and TSC22d3 were observed to be the most elevated
from the point of neck compression to 60 minutes after, while Luc7l was only significantly
elevated after 60 minutes (Takahashi et al. 2009). Due to the fact that mRNA transcripts are
subject to degradation, it is important to study the protein products of the genes studied here to
determine the applicability of these potential biomarkers. In cases of death due to strangulation,
human cardiac tissue samples were observed to have increased expression of Dusp-1 and
potassium voltage-gated channel subfamily J member 2 (KCNJ2) (Zeng et al. 2017). This study
additionally found Dusp-1 and KCNJ2 to be independent of age, PMI, and temperature of the
environment (Zeng et al. 2017). Dusp-1 has appeared to be found significant in strangulation and
warrants further studies, especially in actual protein products after death as well as across other
means of asphyxial deaths.
Discussion
In looking at proteins examined throughout asphyxial deaths, there are noticeable
disparities in the amount of research. Proteins such as aquaporins and surfactant-associated
proteins have been more extensively researched than others, such as apolipoprotein A1 and α-1
antitrypsin. The importance of sampling sites has been shown through proteins that were thought
to be insignificant but later found to be significant dependent on sampling locations, such as
thyroglobulin. In reviewing literature related to asphyxial deaths, it should be noted that most of

the work focuses on deaths related to strangulation, commonly referred to as ‘mechanical
asphyxiation’ in the literature, and drowning. Few studies review the effects of suffocation and
none of the studies mentioned here include mechanical asphyxiation. It should be noted that
some proteins are not examined across multiple asphyxial deaths. It is left to wonder if the
significance of the protein reviewed is significant to that single asphyxial subtype or to asphyxial
deaths in general. While this should not take away from the significance of any findings, it is
important for future studies to clarify potential indiscretions.
Practically all proteins here require further validation before they can be applicable in a
medicolegal autopsy. Strict thresholds must be set and validated across all potential biomarkers.
A majority of reviewed studies examined the significance of elevation to baselines expression
levels of proteins, without specific values. The included table below reflects these findings and
serves as a model for what a potential panel of biomarkers could be.

Table 1: Complied results from reviewed studies related to asphyxial deaths. (+): significant
elevation, (-): no significant elevation or low expression, (+/-): results not significant to cause of
death.
Biomarker

Suffocation

Strangulation

S100B

Serum S100:

Serum S100: + N/A

Serum S100: - S100-

- S100-

S100-

positivity in astrocytes:

positivity in

positivity in

- CSF: -

astrocytes: +

astrocytes: CSF: +/-

Mechanical Asphixa Drowning

SP-A

Serum: -

Serum: -

N/A

Serum: + SP-Apositivity in lung
tissue: +

SP-D

Serum: -

Serum: -

N/A

Serum: + (Saltwater)

Albumin

N/A

Serum: +

N/A

Viterous humor: -

Globulin

N/A

N/A

N/A

Viterous humor: +

N/A

Serum: +/-

N/A

N/A

IHC: -

IHC: - (AQP1,

N/A

IHC: - (AQP1 &

(AQP1,

alveolar

AQP4, renal tissue)

alveolar

epithelial

IHC: + (AQP2, renal

epithelial

cells) IHC: +

tissue, saltwater) IHC:

cells) IHC: +

(AQP3, skin

+ (AQP4, brain tissue,

(AQP5,

tissue) IHC: +

freshwater) mRNA: +

alveolar

(AQP5, intra-

(AQP5)

epithelial

alveolar space)

(IgG, IgM)
Thryoglobu
lin
Aquaporin

cells) mRNA: mRNA: +
- (AQP5)

(AQP5)

Hypoxia-

IHC: - (lung

IHC: - (lung

Inducible

tissue)

tissue) mRNA:

Factor 1

mRNA: -

-

Erythropoie mRNA: -

N/A

IHC: - (lung tissue)
mRNA: -

mRNA: -
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Postmortem Toxicology
Postmortem toxicology is the application of forensic toxicological methodologies to
determine if the presence of a toxin contributed to the cause of death, among other applications.
The severity of a toxin is dependent on its nature and unique thresholds for lethal toxicity; thus, it
is crucial to be able to accurately characterize and quantify these substances. Postmortem
toxicology faces many challenges due to the transformative nature of postmortem physiology, as
well as in the development of methods for detecting and quantifying toxins (Skopp 2010). Drugs
are especially sensitive to postmortem necrokinetics (Skopp 2010). As the current field of
postmortem toxicology is concerned with developing methods directed toward specific detection
of toxins, especially drugs, in biological samples, it has not yet reached a point where research in
regards to additional biomarkers has been thoroughly investigated. Due to this, deaths influenced
by the presence of drugs will not be discussed here.
Proteomic techniques, such as mass spectrometry-based methodologies, have shown
great promise in the analysis of peptide-based toxins, such as anthrax and botulinum neurotoxins
(Aberg, Bjornstad, and Hedeland 2013). Mass spectrometric methods have additionally shown
promise for the detection of drugs, however, a secondary method of analysis is required to

confirm detection through quantification, and complications surrounding accurately assessing
low concentrations and proper thresholds are present (Skopp 2010). The following section of this
review will address the limited studies done on the identification and assessment of potential
biomarkers associated with toxicological deaths.
S100
As well as in deaths related to asphyxiation, the calcium-binding protein S100 has been
evaluated as a biomarker for deaths related to toxins. Paraquat, a common herbicide that induces
lung damage with a high mortality rate after ingestion, was found to be significantly correlated
with elevated serum levels of S100A8 and S100A9 (Wei et al. 2018). Across the 21 human
serum samples from deaths due to paraquat poisonings, transferrin receptor protein 1 (TfR1) and
serum amyloid P-component (SAP) were additionally expressed under typical threshold levels
(Wei et al. 2018). Immunohistochemical analysis of lung tissue of rats subjected to paraquat
poisoning displayed the same results as the sera from the human samples (Wei et al. 2018). The
use of these four proposed biomarkers together show promise in identifying paraquat poisonings.
Phosphide poisonings, often related to pesticides and common in developing countries,
have been observed to display elevated levels of S100B in serum from 29 admitted patients
(Shahin, Abuelfadl, and Zaki 2013). S100B was researched as a predictor of mortality, it was
suggested that significant elevation of serum S100B was associated with an increased mortality
rate (Shahin, Abuelfadl, and Zaki 2013). While postmortem evaluation was not conducted to
determine the diagnostic potential of S100B for phosphide poisonings, this relationship as a
predictor of mortality shows promise for further research. S100B was additionally studied as a
predictor of mortality for organophosphate poisonings (Oreby and El-Madah 2017). Oreby and
El-Madah (2017) observed significant increases in serum S100B in the presence of

organophosphates in admitted and deceased individuals. S100 should be considered for further
study as a biomarker of death related to pesticides. It is additionally important to study a
biomarker across different causes of death under the same classification, such as S100A8 and
S100A9 should be studied in phosphide and organophosphate poisonings to ensure significance
in determining causes of death.
Other Possible Biomarkers of Pesticides
In evaluating deaths related to pesticides, few other rigorous and direct studies have been
conducted. When studying the mechanisms of paraquat poisonings, it was observed that proteins
within the autophagic network are elevated in fatalities due to paraquat (Xu et al. 2019).
Autophagy is thought to be signaled as a result of pulmonary fibrosis, which is induced after
lethal amounts of paraquat is ingested (Xu et al. 2019). Because of this proposed relationship,
autophagic proteins, such as Beclin 1, microtubule-associated protein light chain 3, and
SQSTM1/p62, can be proposed as biomarkers. Xu et al. (2019) observed the elevation of these
autophagic markers in the lung tissue in 8 cases of death due to paraquat poisoning. Further
research is necessary here, especially in the determination of significance to paraquat and not to
the pathophysiology of lung damage at death.
C-reactive protein and copeptin serum levels have been studied as prognostic biomarkers
for organophosphorus poisonings and found to be significantly associated with severity across
100 admitted patients (Wu et al. 2016). As with the research conducted on S100B and
organophosphate poisonings, C-reactive protein and copeptin were not studied in a postmortem
setting, but expression was linked to increased mortality through severity in a clinical setting
(Wu et al. 2016). It is unclear if these proposed biomarkers can be used in a diagnostic
application in a postmortem state, but it is worth further study.

The effects of fluoride poisoning have been studied in rats and found to induce decreased
expression of cytoskeleton proteins (Panneerselvam, Raghunath, and Perumal 2017). Cardiac
tissue samples from 18 rats exposed to fluoride displayed decreased expression of desmin,
vimentin, and vinculin, as well as an increase in AMP-activated protein kinases (Panneerselvam,
Raghunath, and Perumal 2017). As fluoride poisoning is associated with sudden cardiac failure,
it is possible this study revealed physiologic mechanisms of fluoride toxicity and not potential
determinants of death (Panneerselvam, Raghunath, and Perumal 2017). The relationship between
cytoskeleton proteins and AMP-activated protein kinases should be further evaluated in other
causes of death related to sudden cardiac failure.
Pulmonary Surfactant-Associated Protein
In cases of death due to pancuronium bromide and butane poisoning, a high
immunohistochemical score of SP-A was observed in 42 human lung tissue samples (Zhu et al.
2001). A second grade SP-A score was observed in deaths related to organophosphate and
arsenic poisonings (Zhu et al. 2001). It is undetermined if these results are significant to the
cause of death or just a signal of respiratory distress, further research is required before the
diagnostic potential of SP-A can be assessed. A small sample pool of 3 deaths due to muscle
relaxants and organophosphate poisonings found insignificant results for the use of SP-A as a
biomarker (Maeda et al. 2003). It is important to take sample sizes into consideration; however,
based on currently available data SP-A does not display immediate promise as a determinant for
deaths related to toxins.
Troponin, Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1α
A study conducted on 65 rats evaluating the efficacy of predictive and diagnostic
biomarkers of cantharidin-induced fatalities observed elevated serum levels of troponin T (TN-

T), VEGF, and HIF-1α (Youyou et al. 2020). As cantharidin poisonings are associated with
myocardial injury and induced hypoxia, necrosis, and inflammation; it is crucial to interpret
these results in tandem, as VEGF and HIF-1α expression levels are positively associated with
hypoxia conditions (Youyou et al. 2020). While a positive correlation was observed between
these biomarkers and the effects of cantharidin on a biological system, it is important to study
this relationship in depth in humans and in a postmortem setting. Zhang, Liu, and Ren (2020)
observed an elevation of TN-T in the sera of 13 rats exposed to cantharidin. Additionally, RNAsequencing revealed 38 differentially expressed genes (DEGs) between the experimental and
control group (Zhang, Liu, and Ren 2020). It is worthwhile examining the protein products of
DEGs to determine potential significance as determinants of cantharidin-induced fatalities. The
use of serum TN-T levels were found to have high diagnostic efficacy and the ability to remain
stable up to 168 hours after death (Zhang et al. 2020). The use of the ration of HIF-1α/TN-T was
additionally found to present high diagnostic efficacy (Zhang et al. 2020). While VEGF/HIF-1α
were elevated after cantharidin related deaths, the use of this ratio displayed more potential as an
estimator of PMI rather than a diagnostic biomarker (Zhang et al. 2020). However, this use of
serum TN-T as a diagnostic biomarker was focused on myocardial injury induced by cantharidin
in these studies. While there appears to be a potential for high efficacy, it is important to study
expression levels of TN-T across other causes of death, especially those including myocardial
injury to determine significance to cantharidin-induced fatalities. Additionally, Yu et al. (2020)
observed elevation of tumor necrosis factor alpha, IkappaB kinase-alpha, and caspase3 in liver
tissue of rats exposed to cantharidin. While these proteins have not been studied as postmortem
diagnostic biomarkers, they could potentially be regarded as determinants of cantharidin-induced
fatalities. While these studied proteins present as possible biomarkers to help determine the

physiological mechanisms behind toxicity induced fatalities, there is the potential that a
combination of multiple biomarkers could be used to determine causes of death.
While TN-T expression levels have been considered a biomarker of myocardial injuries,
Remmer et al. (2013) observed TN-T can also be significant for differentiating causes of death
related to cardiovascular disease from poisonings. Serum TN-T was found to be independent of
age and gender but was found to be insignificant towards the experimental poisoning group,
which consisted of deaths due to various drugs and diethyl ether (Remmer et al. 2013). Although
deaths related to the influence of drugs are not going to be a focus in this review, this study
reviews the use of TN-T in another pathway of deaths due to toxins. Additionally, the use of
decreased or insignificant expression levels in a sample group are influential in adding to a
potential list of determinants of death.
The significant elevation of serum TN-T has additionally been observed in a death due to
paraphenylene diamine (Jedidi et al. 2016). A larger study done on 1595 patients admitted for the
ingestion of paraphenylene diamine found TN-T to be elevated in 57.5% of the samples (Jain et
al. 2012). Jain et al. (2012) additionally notes that data from deceased patients were discarded
within this study. With these factors and low correlation, reliability is not strongly suggested for
the potential use of TN-T as a diagnostic biomarker in a postmortem setting. However, the
potential application should not be completely discarded until it is confirmed in a postmortem
setting that there is little to no reliable correlation between TN-T expression and paraphenylene
diamine fatalities.
Cardiac troponin C has been recorded to be depleted in myocardial tissue in 4 autopsies
for butane poisonings (Ventura et al. 2017). While troponin C was decreased, fibronectin was
observed to be elevated in myocardial tissue (Ventura et al. 2017). While the relationship

between troponin C and fibronectin were suggestive of the hypoxic myocardial damage induced
by butane inhalation, it is worthwhile studying this relationship in similar causes of death to
determine potential significance to butane fatalities (Ventura et al. 2017). Hu, Chen, and Zhu
(2002) studied the potential postmortem application of fibronectin and found fibronectin to be
insignificant to deaths due to organophosphate poisonings and strangulation. Extensive research
is required to determine the validity of the potential use of troponin C and fibronectin, but
potential significance exists.
Bcl-2
Bcl-2 is a protein involved with apoptosis regulation and has been considered as a
contributing factor of pulmonary fibrosis (Roshanzamir et al. 2008). As pulmonary fibrosis is
being studied as a cause of death for sulfur mustard-induced fatalities, Bcl-2 has been considered
as a biomarker for sulfur mustard related deaths (Roshanzamir et al. 2008). In a study of 13 lung
tissue samples from sulfur mustard related deaths, Bcl-2 was found to be upregulated in
fibroblasts and epithelial cells (Roshanzamir et al. 2008). Previous studies looking strictly at the
relationship between pulmonary fibrosis and expression of Bcl-2 have found unremarkable
results and are reported to be not well justified (Roshanzamir et al. 2008). Roshanzamir et al.
(2008) provide the first study to report on significant elevation of Bcl-2 within fibroblasts and
epithelial cells of lung tissue from sulfur mustard fatalities.
A study conducted on rats after macleaya cordata alkaloids poisoning found Bcl-2 and
Bax proteins to be significantly elevated in myocardial tissue (Zhang et al. 2009). An additional
study conducted on rats found the ratio of Bax/Bcl-2 to be significantly elevated in lead
poisonings (Sharifi et al. 2002). Further studies on rats measuring Bax and Bcl-2 found Bcl-2 to
display decreased expression in response to cadmium but elevated expression following

endurance training (Ghajari, Hosseini, and Farsi 2019). Cadmium exposure increased Bax
expression and endurance training had reduced Bax expression (Gharjari, Hosseini, and Farsi
2019). While this study did not directly examine the postmortem effects of cadmium poisoning,
it illuminates the complex relationship of Bcl-2 and Bax protein expression. Bcl-2 and Bax
expression levels may be more reliable in understanding disease and physiological functions
rather than as diagnostic biomarkers for causes of death due to how widespread elevated
expression has been reported.
Alkylated Albumin-Derived Dipeptides
The detection of sulfur mustard is crucial and novel biomarkers are being developed
through analyzing the protein it alkylates (John et al. 2019). Sulfur mustard can alkylate proteins
such as keratin, hemoglobin, and albumin and create protein adducts with an extended half-life
(Richter et al. 2021). Richter et al. (2021) researched an alkylated albumin-derived dipeptide, C(HETE)P. After being derivatized to PA-C(-HETE)P, this biomarker was found to be reliably
detected in tandem with sulfur mustard exposure within ranges that are toxicologically relevant,
32 nM to 50 μM (Richter et al. 2021). Richter et al. (2021) significantly linked the use and
detection of C(-HETE)P and PA-C(-HETE)P in plasma samples of sulfur mustard victims after
15 days of exposure. The derivative NA-C(-HETE)P has additionally been found to increase the
lower limit of sulfur mustard detection, to 80 nM, through mass spectrometry methods (John,
Richter, and Thiermann 2021). NA-C(-HETE)P was additionally verified through plasma
samples of people exposed to sulfur mustard (John, Richter, and Thiermann 2021). While these
novel biomarkers show great promise in the detection of sulfur mustard, it is unclear if a
postmortem application has been studied. The validity of these biomarkers requires postmortem
analysis for their potential application and reliability. Steinritz et al. (2021) additionally studied

the use of creatine kinase B-type as a local biomarker for skin exposure to sulfur mustard with
promising results. However, further studies are required to validate the practical use and
postmortem application.
Protein-Bound Thiocyanate
The evaluation of biomarkers for cyanide poisonings is crucial for determining exposure
and protein-based biomarkers can offer more stability (Youso, Rockwood, and Logue 2012).
Protein-bound thiocyanate (PB-SCN) has been considered as a biomarker due to its stability and
extended half-life when compared to cyanide itself (Youso, Rockwood, and Logue 2012).
However, PB-SCN faces complications if the cyanide concentration is expected to be small due
to physiological background levels of thiocyanate potentially signaling false positives (Youso,
Rockwood, and Logue 2012). Youso, Rockwood, and Logue (2012) researched low levels of
cyanide exposure and its relationship to plasma PB-SCN and found a strong correlation between
PB-SCN concentration and people who smoke, a sample group exposed to cyanide at a higher
than typical rate. While this study supports the potential application of PB-SCN as a biomarker
for cyanide exposure, more research needs to be done regarding potential tolerance, as most
people are exposed to the toxin at some dose throughout their lives. More research also needs to
be conducted to evaluate post-mortem analysis implications. However, the use of gas
chromatography-mass spectrometry to analyze PB-SCN has been validated and reported to be
able to detect levels as low as 2.5 ng mL-1, which is below what is estimated to be the chronic
low cyanide exposure level (Youso et al. 2010). Additionally, 2-aminothiazoline-4-carboxylic
acid (ATCA) has been considered as a biomarker for cyanide poisonings due to its storage
stability, but PB-SCN is thought to be advantageous due to the extended half-life (Logue et al.
2010). As analytical methods become further developed to ease the time and cost of current

methods, PB-SCN is a very promising biomarker in confirming and determining the scale of
cyanide exposure (Logue et al. 2010).
Additional Potential Biomarkers
Few other proteins have been studied in detail as potential biomarkers for deaths related
to toxins. In researching mechanisms behind snake venom poisonings, Kininogen-1 and
orosomucoid 1 were identified in a rat study to be significantly elevated in the presence of
Chinese cobra venom (Yan et al. 2017). In researching the effects of methanol, glial fibrillary
acidic protein was observed to be significantly elevated in brain and optic nerve tissue (Turkmen
et al. 2008). Decreased expression of CD34 was additionally correlated with methanol toxicity
(Turkmen et al. 2008). More research is necessary to validate the relationship between these
potential biomarkers and their associated cause of death before postmortem application. In
evaluating these relationships, it is also important to consider fatalities due to related toxins to
ensure specificity of the proposed biomarker.
Discussion
The application of novel peptide-based diagnostic biomarkers within postmortem
toxicology is not well developed. This is largely due to the current state of research within
postmortem toxicological is concerned with the specific development of toxins themselves.
Specific detection of toxins is challenged by the biological changes that occur due to a
postmortem state, such as putrefaction and the redistribution of a toxin, as well as the general
breakdown of toxins that can occur during the agonal period (Skopp 2010). Detection and,
especially, quantification of toxins are further complicated by antemortem factors such as
personal tolerance levels, interference from prescription drugs, and pharmacokinetics (Skopp
2010). Methodologies for specific toxin detection favor LC/MS and GS/MS, but these still face

challenges in the accurate detection of low concentrations (Skopp 2010). While novel proteomic
biomarkers have not been studied in-depth, some, especially the potential use of C(-HETE)P for
the detection of sulfur mustard, have shown great potential in being able to detect evidence of
toxins at lower concentrations. Proteomic biomarkers additionally offer promise in postmortem
stability and predictable postmortem effects, where specific detection of toxins may face greater
challenges.
Due to the widespread nature of the reviewed potential biomarkers, a table will not be
included in this section. Additional proteomic biomarkers in postmortem toxicology have not
been studied across multiple causes of death, as seen in studies related to asphyxial and traumatic
deaths, therefore, as of now individual sections reviewed here can be interpreted as independent
of each other. Future research into the relationship of proposed biomarkers across multiple kinds
of toxicological deaths can contribute to the potential creation of a cohesive toxicological panel.
As of now, the examined studies provide a foundation for future research on proposed diagnostic
biomarkers for validity and reliability in a postmortem application. Predominantly, S100 holds
potential for deaths related to pesticides, troponin T is promising for cantharidin fatalities,
alkylated albumin-derived proteins hold great potential for sulfur mustard, as well as PB-SCN
for cyanide poisonings. While these biomarkers have been observed to have significant
expression levels within their respective studied causes of death; it is crucial to cross-study these
across multiple causes of death, especially in deaths that can present similarly to each other or be
the result of the same pathological mechanisms. The use of SP-A and Bcl-2 show less immediate
promise through the reviewed studies in their diagnostic ability, but they should not be entirely
discounted until it has been strongly shown there is no applicable significance.
Trauma

Within forensic death classification, traumatic deaths include those that result from
injuries caused by projectiles, sharp, or blunt force objects. Determination of the cause of a
traumatic death during a medicolegal autopsy is often benefitted by the external examination,
however, it is important to note if bodily trauma is the primary cause of death or secondary to it
(Campobasso et al. 2015). Sharma et al. (2007) discusses the rate of injuries missed if medical
intervention is present; for example, blunt force trauma and resuscitation events are reported to
be associated with a higher likelihood of underreported injuries. Unrelated trauma to the body
and lack of prior documentation and context can also contribute to difficulties in assessing
traumatic deaths. It is additionally plausible for wounds to be difficult to differentiate; for
example, in one case stab wounds were mistaken for blunt force trauma due to falling down a
staircase (Campobasso et al. 2015).
Due to uncertainties, medicolegal autopsies are required in cases of violent deaths to
ensure proper diagnoses are made. Extensive legal implications are present as, outside of
fatalities due to motor vehicle accidents, a sufficient number of traumatic deaths are linked to
homicide (Simon, Lopez, and King 2022, CDC 2022). Accurate determination of the cause of
traumatic deaths is crucial to understanding if injuries are intentional, defensive, or self-inflicted.
While cause of death is not completely linked to intent, it provides another piece of evidence.
This paper will discuss potential biomarkers and their diagnostic efficacy in violent deaths.
For the purposes of this paper, traumatic deaths will be classified as being due to blunt
force injury, sharp force injury, and projectile injuries. Blunt force induced traumatic deaths
include a wide variety of injuries, such as automobile crashes, falls, and blunt impact injuries
(Simon, Lopez, and King 2022). Sharp force injuries are inclusive of the use of a weapon with
the ability to penetrate or break the skin, such as a knife (Schmidt 2010). Deaths due to

projectiles are inclusive of the use of firearms and can additionally be referred to as high-velocity
traumatic deaths (Adserias-Garriga 2019). In assessing traumatic deaths, the agonal period is of
special interest. The agonal period, also referred to as the survival period, is the terminal phase of
life which occurs between fatal injury and death (Rosato et al. 2021). In this paper, acute death
will be classified as an agonal period less than 6 hours, and non-acute deaths will be associated
with an agonal period greater than 6 hours.
S100
The cause of traumatic deaths can be difficult to determine, especially those pertaining to
blunt force trauma to the head. S100B, the subunit of S100, has been discussed as a potential
postmortem biomarker of lethal traumatic brain injuries due to the abundance of S100B in the
central nervous system (Li et al. 2006). Clinical studies first noted the correlation between
elevated serum levels of S100B and increasing severity of head trauma (Rothoerl et al. 1998,
Regner et al. 2001). After finding expression levels of S100B to be independent of age and
gender, it was regarded as a predictive biomarker of traumatic brain injuries in clinical settings
(Vos et al. 2004, Pelinka et al. 2004). However, Anderson et al. (2001) observed elevation of
serum S100B in patients without head trauma, such as following heart surgeries or bone
fractures. This emergent relationship between elevated serum S100B and head trauma led to
further postmortem studies to determine the potential application in a diagnostic capacity.
However, a high degree of specificity is required before a clinical biomarker can be applied to a
postmortem setting.
In studying the postmortem application, Li et al. (2006) observed elevated serum levels
of S100B, sampled from right heart blood (RHB) and the subclavian vein, to be significantly
elevated in acute deaths due to blunt force trauma to the head. This sample study of 283 cadavers

additionally found serum S100B to be stable up to 48 hours post-mortem, independent of age and
gender; as well as noting serum samples taken from the subclavian vein to be the most
consistently elevated and serum samples from left heart blood (LHB) to be the lowest (Li et al.
2006). Deaths due to blunt force trauma without head injury or due to sharp force injuries were
observed to display lower but still significantly elevated levels of serum S100B (Li et al. 2006).
Additionally, it should be noted that serum S100B concentrations sampled from LBH followed
similar elevation trends without significance, which raises questions about the influence of the
postmortem state (Li et al. 2006). While this study supports the use of serum S100B as a
potential diagnostic biomarker, the specificity of serum S100B concentrations to lethal head
trauma is still unclear, especially in determining the presence of head trauma compared to
determining the cause of death.
Immunohistochemical (IHC) analysis of S100B in astrocytes revealed an inverse
relationship to serum concentrations in cases of traumatic deaths (Li et al. 2006). Li et al. (2006)
observed low S100-positivity in astrocytes in cases of death due to blunt force, sharp force, and
projectiles. However, S100-positivity was observed in myelin in non-acute cases of death due to
blunt force head trauma (Li et al. 2006). This was additionally observed in neurons and
correlated with the agonal period (Li et al. 2006). IHC analysis in this study provided significant
results when compared to other causes of death, such as drowning (Li et al. 2006). Multiple
methods of analysis are key in understanding a potential biomarker’s specificity and reliability
when being linked to one cause of death. While S100B does not immediately propose high
specificity to lethal blunt force injuries, the combination of methods, as well as other biomarkers,
aid in increasing validity.

S100B concentrations sampled from cerebral spinal fluid (CSF) have been observed to be
significantly elevated in deaths due to blunt force trauma to the head (Li et al. 2009). Li et al.
(2009) proposed a threshold of S100B sampled from CSF at 2000 ng/mL to be significant for
fatal brain damage and did not believe S100B to be correlated with the agonal period. However,
Sieber et al. (2018) observed similar findings but found S100B concentrations in CSF to increase
with survival time. Sieber et al. (2018) recorded a median CSF level of S100B to be between
6636-7451 ng/mL depending on cerebral tissue damage but noted a significant difference across
lethal head traumas with differing agonal periods. It was additionally noted the serum sampling
of S100B showed no significance in differentiating causes of death (Sieber et al. 2018). While
consistent observations of elevation of S100B, especially when sampled from CSF, present as a
favorable potential diagnostic biomarker, further research is necessary to ensure reliability and
validity. This is especially important to determine the relationship between S100B and the agonal
period compared to the cause of death.
Glial Fibrillary Acidic Protein
Glial fibrillary acidic protein (GFAP) is a protein found exclusively in the nervous
system and has been regarded as a clinical marker for damage to the central nervous system
(Nylen et al. 2006). In a clinical setting, a measurement over 6.98 μg/L of serum GFAP is
thought to be predictive of a lethal traumatic head injury (Nylen et al. 2006). Serum GFAP has
been thought to have a higher specificity to head trauma than serum S100B because serum
GFAP has not been observed to be elevated in cases of hemorrhagic shock without brain injury,
where serum concentrations of S100B were elevated (Pelinka et al. 2004). Nylen et al. (2006)
further discounted S100B’s specificity to the nervous system through observing expression in
other tissues, such as fat and muscle tissue. GFAP is understood to be strictly found in nervous

tissue as it is a structural protein associated with astroglia (Nylen et al. 2006). These factors
contribute to the potential of GFAP being used as a postmortem diagnostic biomarker at a higher
specificity than S100B for deaths involving head trauma.
Serum and CSF concentrations of GFAP sampled from 84 cadavers revealed elevated
expression in cases of death due to head trauma (Ondruschka et al. 2018). Ondruschka et al.
(2018) set threshold levels for GFAP to be greater than 385.5 ng/mL in CSF and greater than
0.91 ng/mL in serum to be significant for lethal head trauma. However, a study done on 129
cadavers found elevation of serum GFAP to be insignificant to the cause of death, but rather
significant to survival time (Breitling et al. 2018). Breitling et al. (2018) observed serum GFAP
to be increasingly elevated with increased agonal periods. Due to this, serum GFAP is thought to
be too heavily influenced by the perimortem period to be significant in determining cause of
death.
Neri et al. (2018) observed significant GFAP-positivity in brain tissue from non-acute
deaths with traumatic head injuries. This immunohistochemical analysis may initially be thought
of as a significant finding towards cause of death, but it is likely more specific to the agonal
period due to the observations made by Breitling et al. (2018). Additionally, GFAP-positivity has
been observed in tandem with brain injuries including brain disease, which further complicates
the use of GFAP as a marker of traumatic brain injury depending on medical histories (Zwirner
et al. 2021). While GFAP appears to be a potential diagnostic biomarker for blunt head injury
deaths, more research is required to determine significance to cause of death, agonal period, and
brain pathology.
Neuron-Specific Enolase

Neuron-specific enolase (NSE), a protein specific to neurons, has been determined to
have increased expression following head trauma. NSE has also been examined as a potential
postmortem biomarker for deaths caused by brain injury (Zurek and Fedora 2012, Vos et al.
2004). In studying the postmortem application of NSE, Sieber et al. (2018) found CSF
concentrations of NSE to be elevated in cases of death with lethal head injuries. Analysis of NSE
levels in CSF in relation to the agonal period did not reveal any significant trends, whereas
analysis of S100B levels did (Sieber et al. 2018). Analysis of serum concentrations of NSE have
shown to be insignificant for determining cause of death (Sieber et al. 2018, Zwirner et al. 2022).
The use of CSF sampling has shown to have the most reliability so far in differentiating deaths
associated with lethal head injuries compared to deaths associated with isolated torso trauma,
diffuse cerebral hypoxia, and sudden natural deaths (Sieber et al. 2018, Zwirner et al. 2022). It is,
however, undetermined if the use of NSE can differentiate between lethal and nonlethal head
injuries. Preliminary work has been done to assess this relationship and it has been observed that
a threshold value of 599 ng/mL NSE sampled from CSF can determine an acute, under 2 hours,
lethal head injury with a specificity of 97% and reliability of 83% (Zwirner et al. 2022).
Interleukin-6
Interleukin-6 (IL-6), a proinflammatory cytokine, has been evaluated for its potential
diagnostic efficacy as a biomarker of traumatic injuries. IL-6 has specifically been studied as a
biomarker of wound vitality and was found to be highly elevated and observed to increase with
time in wounds that were a result of sharp force injury (Grellner and Wilske 2000). Further
immunohistochemical analysis of IL-6 revealed promising results as a biomarker to determine
wound age and vitality (Grellner 2002). Expression of IL-6 was first observed 20 minutes after
the incident of a sharp force injury, was most elevated 6 hours after, and elevation persisted up to

6 days (Grellner 2002). Grellner (2002) additionally observed that tracking the specific
expression of IL-6 was more favorable than tracking the expression of TNF-α or IL-1β. While
expression of IL-6 in skin tissue appears promising for determining the vitality of wounds, it
does not appear to be applicable for determining cause of death. More research is required to
establish time dependent thresholds of IL-6 expression and assess the relationship of IL-6
expression to wound severity.
Expression of IL-6 in direct regard to traumatic deaths has been studied in over 100
cadavers with varying degrees of chest trauma, including blunt, sharp, and projectile injuries as
well as combined and isolated traumas (Hammad et al. 2019). Traumatic deaths were observed to
display elevated serum levels of IL-6 when compared to non-traumatic deaths with and without
myocardial infarction (Hammad et al. 2016). The combined traumatic death group was
additionally observed to display higher serum levels of IL-6 than isolated injuries (Hammad et
al. 2016). The elevation of serum IL-6 in polytraumas compared to isolated injuries suggests the
use of IL-6 to be more specific to the degree of trauma, rather than cause of death (Hammad et
al. 2016). Further studies are necessary to determine the relationship between serum IL-6 levels
and cause of death, especially between the subgroups of traumatic deaths.
Research on the use of IL-6 revealed CSF concentrations of IL-6 to be more
significantly elevated in cases of death due to traumatic brain injury compared to deaths due to
isolated chest trauma (Zwirner et al. 2022). Postmortem CSF levels of IL-6 were additionally
shown to be significant for lethal acute traumatic head injuries at 86% accuracy and 96%
specificity after IL-6 concentrations reach the proposed threshold of 99.1 pg/mL (Zwirner et al.
2022).
Neutrophil Gelatinase-Associated Lipocalin

Neutrophil gelatinase-associated lipocalin (NGAL) has been regarded as a biomarker of
acute renal injury, and urinary concentrations of NGAL have been treated as a reliable marker
for the diagnosis of acute kidney injury (Makris et al. 2008). Recently, NGAL has been
considered as a biomarker for traumatic head injuries. In a clinical setting, a proposed threshold
has been set at 244.13 ng/mL for serum NGAL levels to be indicative of severe traumatic head
injury at 84% accuracy and 78.9% specificity (Zhao et al. 2016).
Ondruschka et al. (2018) observed postmortem CSF NGAL levels to be significantly
elevated in cases of death due to traumatic head injuries. Additionally, the CSF NGAL levels
were able to differentiate between traumatic deaths with and without head injuries (Ondruschka
et al. 2018). This finding opens the possibility that CSF NGAL expression levels may be able to
differentiate between specific causes of death, but more research is necessary. Ondruschka et al.
(2018) set a threshold value of 1050.5 ng/mL for CSF NGAL with a specificity of 89.7% and
accuracy of 72.7%. Additionally, CSF NGAL showed significance to cerebral hypoxia that
additionally proposes potential significance for being a biomarker in deaths due to asphyxiation
(Ondruschka et al. 2018). While serum NGAL has not been studied, the use of CSF NGAL
proposes good potential as a postmortem diagnostic biomarker for blunt force fatalities with head
injury. Currently, the use of CSF NGAL has a low specificity and accuracy and further research
is necessary. CSF NGAL may be useful as a biomarker for specific types of trauma death when
combined with other relevant biomarkers.
Brain-Derived Neurotrophic Factor
Brain-derived neurotrophic factor (BDNF) has been studied in cases of traumatic brain
injury due to its prevalence in the nervous system. In a study conducted across 84 cadavers,
Ondruschka et al. (2018) observed serum concentrations of BDNF were unable to significantly

differentiate traumatic causes of death while CSF concentrations of BDNF were significantly
elevated in acute cases of death due to head trauma. Despite this significant elevation, the use of
CSF BDNF was found unable to differentiate between blunt force injuries with and without head
trauma, whereas CSF GFAP and NGAL were able to (Ondruschka et al. 2018). Ondruschka et al.
(2018) set a threshold of 29.0 pg/mL for CSF BDNF to be significant of acute lethal head
traumas with a specificity of 83.3% and accuracy of 71.0%. Additionally, it was observed that
CSF BDNF is not affected by the agonal period (Ondruschka et al. 2018).
Zwirner et al. (2021) corroborated these results and observed elevated CSF
concentrations of BDNF, especially in tandem with NGAL, ferritin, and LDH, to be significant
of acute lethal head trauma. A proposed threshold of 11.1 pg/mL of BDNF from CSF is reported
to be significant of acute lethal head trauma with an 86% accuracy and 96% specificity (Zwirner
et al. 2022). The use of CSF BDNF as a potential diagnostic biomarker for acute deaths with
blunt force injury to the head shows great promise.
Lactate Dehydrogenase
Lactate dehydrogenase (LDH), a common digestive enzyme, has been reported to be a
significant indicator of head trauma when sampled from CSF (Vazquez et al. 1995). Zwirner et
al. (2022) observed the use of CSF LDH to be able to significantly differentiate between deaths
due to blunt force trauma with and without head injury or cerebral hypoxia. The use of serum
LDH only revealed significance with lethal blunt force injuries that do not include the head
(Zwirner et al. 2022). Because of this, the use of CSF LDH is more specific to lethal head trauma
than serum LDH. Zwirner et al. (2021) proposed a threshold of 16.71 ukat/l when measuring
postmortem levels of CSF LHD for lethal acute head injuries. This threshold is reported to be

significant for acute lethal head injuries with an accuracy of 81% and a specificity of 97%
(Zwirner et al. 2021).
Ferritin
Ferritin is an acute phase protein that has been studied as a potential biomarker of lethal
blunt injuries to the head. Zwirner et al. (2022) has proposed a threshold of 8.0 mg/L for CSF
levels of ferritin to display significance of lethal head injuries, while concentrations under this
threshold may be significant for deaths due to blunt force injuries not including the head and
myocardial infarctions. While the initial elevation of CSF ferritin may seem promising to lethal
blunt force head injuries, the use of CSF may not have the necessary specificity to be a reliable
and valid postmortem diagnostic biomarker. Additionally, the application of CSF ferritin may be
significant of non-acute deaths in general, as Ondruschka et al. (2018) only observed elevated
expression in deaths with an agonal period greater than two hours. Further research is necessary
to evaluate this relationship.
C-Reactive Protein
C-reactive protein (CRP) is an acute phase protein that functions alongside cytokines
such as IL-6 and responds to inflammation. Research on the potential postmortem application,
specifically on the influence of the postmortem state, of serum CRP revealed postmortem
concentrations are reduced by 35% compared to antemortem concentrations (Uhlin-Hansen
2001). Serum concentrations of CRP can rise to 50-300 mg/L in response to inflammation,
compared to a typical level of under 10 mg/L, the postmortem decline should have no effect on
measuring a change in protein level (Uhlin-Hansen 2001). However, this decrease could make it
difficult to establish a strong threshold for possible determination of cause of death. Stringent
studies are required to detail the effects of postmortem changes on serum CRP concentrations.

Fujita et al. (2002) observed serum CRP to be elevated in non-acute blunt injury deaths,
with a median of 3.68 mg/dL CRP taken from RHB across 408 autopsies. In this study, the
threshold for significant elevation of postmortem CRP levels was set to be greater than 0.5
mg/dL, specifically for sampling within 48 hours (Fujita et al. 2002). Fujita et al. (2002)
observed changes in sampling sites and PMI had no effect on CRP concentration. Ondruschka et
al. (2018) observed similar findings in deaths due to lethal blunt head injuries that showed a
positive correlation with an elevation of CRP in CSF and increasing survival time. Serum
concentrations of CRP appear to be more strongly correlated with the agonal period rather than
cause of death due to its significance towards non-acute deaths.
Astrup and Thomsen (2007) propose use of CRP in a postmortem setting as a marker of
non-acute lethal traumatic injury. Because CRP is relatively stable after death and easy to detect,
it can be easily used as a tool to aid in decision making (Astrup and Thomsen 2007). The
potential use of CRP as a determinant for a wider variety of deaths stands to be beneficial as
another piece of evidence that narrows down possible diagnoses. Reliable groupings could be
created where CRP elevations are present, as it has been associated with blunt injury, fire
fatalities, and a number of pathological causes (Astrup and Thomsen 2007). Nevertheless, even if
CRP is not significant towards just one cause of death, the application of it could aid in
collecting information, especially with its significance towards the agonal period and a potential
group of deaths.
Thyroglobulin
Thyroglobulin (Tg) has additionally been studied as a potential biomarker for asphyxiarelated deaths. Muller, Franke, and Koch (1997) used deaths due to sharp force injuries as
controls and observed no significant elevation of serum Tg. In 57% of 151 deaths due to blunt

force injuries to the head significant elevations of serum Tg have been observed (Dressler and
Muller 2006). Due to the low correlation with significant elevation of Tg and cause of death,
stringent experimental groups controlling for the agonal period should be conducted.
Additionally, Tani et al. (2020) observed no significant elevation of serum Tg in cases of
traumatic death, but observed elevations of triiodothyronine in acute lethal blunt head injuries.
Further research is required to determine potential significance and it could be beneficial to
validate results through additional sampling methods.
Microtubule-Associated Protein Tau
Microtubule-associated protein Tau (MAPT) has been considered as a potential
biomarker of localized head trauma due to its centralized nature in the central nervous system.
Increases in MAPT concentrations have been correlated with head injuries in clinical settings
and, postmortem research has been conducted to determine potential specificity and reliability
when it comes to determining causes of death (Olczak et al. 2017). Olczak et al. (2017) observed
that serum and CSF MAPT levels were significantly elevated in cases of death due to lethal head
injury. Significant elevation of MAPT associated with head trauma occurred regardless of head
trauma being the lethal factor; therefore, the use of MAPT may be helpful to determine the
presence of head trauma but insignificant for cause of death (Olczak et al. 2017). Further studies
into this application of MAPT, sampled from CSF, revealed the use of MAPT in detecting mild
to severe head trauma that may be morphologically insignificant (Olczak et al. 2018).
MAPT expression has been analyzed through saliva and urine samples, which were
observed to show significant elevation in cases of death associated with head trauma, while
vitreous humor samples were insignificant (Olczak et al. 2019). The ability to sample MAPT

from four different sites adds to its potential application as a postmortem biomarker as sampling
sites can be limited during medicolegal autopsies due to external factors.
Due to the evaluation of MAPT being most likely insignificant towards determining the
cause of death, the potential relationship to time of death determination has been considered.
Peyron et al. (2021) conducted a preliminary study and observed CSF MAPT to be more
elevated when PMI was less than 6 hours. More research is required to determine the potential
validity of a postmortem application of MAPT. Research should be conducted to determine the
relationship between MAPT and PMI as well as to the other subtypes of traumatic death to
ensure specificity to localized head trauma.
Pulmonary Surfactant-Associated Proteins
In studying the relationship between SP-A expression and cause of death, Ishida et al.
(2000) observed postmortem serum levels of SP-A to be generally low in deaths associated with
polytrauma, but elevated in blunt force trauma. SP-A was observed to be more elevated in blunt
force trauma localized to the chest and low in sharp force injuries (Ishida et al. 2000). While
serum concentrations of SP-A did display elevation trends in these cases of death, the use of a
mRNA-assay on lung tissue to provide results did not display significant elevation of SP-A for
blunt force traumas without head injury (Maeda et al. 2003). Quan et al. (2009) proposed that the
elevation of SP-A and SP-D could be associated with traumatic deaths including acute
respiratory distress syndrome, but further research is required to validate this relationship.
Aquaporins
Aquaporins (AQP) have been studied for their potential application as vitality markers of
wounds. Prangenberg et al. (2021) observed AQP3 expression to be elevated in mechanical,
blunt, and sharp, and thermal skin injuries. However, AQP3 expression does not seem to be able

to differentiate between types of injuries, but rather potentially just vitality. This relationship has
been applied to potential differentiation of asphyxiation subclasses.
Prangenberg et al. (2021) observed AQP1 expression to be insignificant to epidermal
injuries; but AQP1, along with AQP4 and VEGF, was observed to significantly expressed in
astrocytes in edematous tissue from head injuries across 6 autopsies (Suzuki et al. 2006). Further
research into postmortem applications revealed AQP4 expression to be progressively elevated
with increased agonal periods following lethal head traumas (Neri et al. 2018). Further research
should be conducted to evaluate the relationship between AQP1 and AQP4 expression in lethal
head injuries and the agonal period to determine potential significance.
Hypoxia-Inducible Factor 1, Erythropoietin, Vascular Endothelial Growth Factor
Hypoxia-Inducible Factor 1 (HIF-1α), Erythropoietin (EPO), and Vascular Endothelial
Growth Factor (VEGF) have been studied for their potential relationship with causes of death.
RNA transcript analysis from renal tissue revealed HIF-1α and EPO expression to show no
significance for traumatic deaths, and VEGF expression to be elevated in acute deaths due to
blunt and sharp force injuries (Zhao et al. 2006).
Quan et al. (2008) observed serum EPO concentrations to be insignificant for
determining the presence of head trauma, but serum EPO levels were elevated in deaths due to
blunt force injury dependent on the duration of the agonal period. Because of this finding, the
application of EPO may be more beneficial in determining agonal periods rather than cause of
death. Postmortem serum EPO levels have shown significant elevation for major vessel sharp
injury deaths with an agonal period of 1-2.5 hours (Quan et al. 2010). Serum EPO levels were
additionally found to be significantly elevated in blunt injury death with massive hemorrhage
and an agonal period of 1-6 hours (Quan et al. 2010). The analysis done by Quan et al. (2010)

comparing specific subtypes of traumatic deaths with varying agonal periods contributes to the
potential use of EPO in a postmortem application that should be further investigated. The
application of VEGF has not been further studied in traumatic deaths, but due to it’s promising
potential in the use of asphyxial deaths, it is worth further study.
Heme Oxygenase-1
Heme oxygenase-1 (HO-1) is a heat shock protein that has been observed to be elevated
following brain injury in rats (Fukuda et al. 1995). IHC analysis on brain tissue following fatal
head injuries from 33 autopsies revealed HO-1-positivity in neurons and microglia that were
observable up to a seven-day agonal period (Orihara et al. 2003). The postmortem application of
HO-1 in relationship to traumatic deaths has not been further studied yet. Future studies to
determine the relationship of HO-1 levels to cause of death, especially compared to the other
subtypes of traumatic deaths or to the agonal period, would be beneficial.
Albumin
Albumin (Alb), one of the major blood serum proteins, has not been significantly linked
to traumatic deaths based on the reviewed research. Quan et al. (2009) observed serum albumin
levels to be higher in acute deaths compared to non-acute deaths related to blunt trauma. This
elevated expression was only significant in non-acute deaths related to blunt trauma involving
the head. It is undetermined if albumin levels are significant to the agonal period or to cause of
death (Quan et al. 2009). Additionally, there were no significant differences observed in deaths
related to sharp force injuries (Quan et al. 2009). Further research is required to determine the
significance of albumin to cause of death.
Myoglobin

Myoglobin, an oxygen delivery protein prominent in muscle tissue, has been studied in
relation to cause of death differentiation. Zhu et al. (2001) observed postmortem serum
myoglobin levels to be likely affected by postmortem changes and urinary levels to be
independent of these changes over 210 autopsy cases. It was observed that urinary myoglobin
levels were significantly elevated in cases of death with an agonal period greater than a half hour
and highest expression was found in agonal periods over 24 hours (Zhu et al. 2001). Elevated
urinary myoglobin was observed in deaths due to polytraumas with an agonal period of less than
24 hours (Zhu et al. 2001). Due to urinary myoglobin expression being more strongly correlated
with the duration of the agonal period rather than situations of trauma, myoglobin may not be
strongly indicative of cause of death (Zhu et al. 2001).
Immunohistochemical analysis of myoglobin in renal tissue revealed upregulation in
cases of death related to blunt and sharp force trauma, with the strongest correlation to sharp
force injury deaths (Ishikawa et al. 2007). Ishikawa et al. (2007) additionally observed
myoglobin-positivity to be not strongly associated with blunt force injury, and ultimately related
to the agonal period instead of cause of death. Myoglobin sampled from pericardial fluid and
CSF has been observed to be low in non-acute cases of death due to head trauma (Wang et al.
2011). While the findings from Wang et al. (2011) contradict the observed correlation between
elevated myoglobin with increasing agonal periods, previous studies have not separated blunt
force trauma groups by the inclusion of head trauma. More research is necessary to determine
myoglobin’s relationship and potential significance to the agonal period or to cause of death.
Troponin
Troponin, a structural muscle tissue protein, has been studied in regard to it’s potential
relationship to cause of death. Cardiac troponin T has been able to be used as a clinical marker of

heart damage, including with the postmortem application of detecting myocardial infarctions
(Twerenbold et al. 2012, Zhu et al. 2006). Serum cardiac troponin T was observed to be elevated
in cases of death related to sharp force trauma over 405 autopsy cases (Zhu et al. 2006).
However, Zhu et al. (2006) observed pericardial and heart blood troponin T to be affected by
postmortem time but still potentially significant for the determination of nontraumatic deaths, as
the injury deaths studied only provided intermediate results if proper thresholds were set. Wang
et al. (2011) observed no significant elevation of cardiac troponin I, sampled from pericardial
fluid, in non-acute deaths due to head trauma.
Peter et al. (2006) found serum troponin T levels in cardiac blood to be significantly
positively correlated with the autolytic process, while serum troponin C and troponin I were only
positively correlated across 36 autopsies. Serological samples from venous blood did not show
correlation with autolysis; but during an agonal period of 1-8 hours, cardiac troponin T and
troponin I were significantly correlated (Peter et al. 2006). Despite these influences, significant
elevation of cardiac troponin C and troponin I are present in cases of death due to chest trauma
(Peter et al. 2006). Peter et al. (2006) recommends the use of these two serological markers up to
a 40-hour PMI to minimize influence from the autolytic process to be significant of Contusio
cordis, which refers to damage to the heart often due to blunt force trauma to the torso. The
guidelines set by Peter et al. (2006) are worth further investigation to determine reliability and
validity but display promise.
Discussion
A large proportion of research done on potential diagnostic biomarkers for traumatic
deaths have been centered around the determination of traumatic head injuries. The work
reviewed here additionally supplies a framework of how postmortem biomarkers are often

translated from clinical prognostic or diagnostic biomarkers, although, the criteria for potential
postmortem application are incredibly strict due to the implications that exist in the legal system.
Due to the extensive work required to validate a postmortem biomarker, a sizeable proportion of
research has postulated the reviewed biomarkers here to be significant of the agonal period rather
than cause of death. Biomarkers related to sharp force trauma and projectiles have not been
studied in similar depth, likely due to morphological supplementation during a medicolegal
autopsy.
From the reviewed proteins here, the use of S100B, NSE, IL-6, BDNF, and LDH together
when sampled from CSF show promise for the detection of acute deaths due to blunt force head
trauma. Proteins NGAL, EPO, and cardiac troponin I and troponin C have been less rigorously
studied but show promising results that should be further explored. Aquaporins, VEGF, and HO1 have not been studied in-depth and their relationship to cause of death or to the agonal period
has not been determined. In assessing the potential significance to the agonal period, GFAP,
ferritin, and myoglobin may be significantly correlated, while MAPT may be significantly
correlated to PMI rather than cause of death. The potential use of CRP has shown promise for the
diagnosis of non-acute lethal traumatic deaths nonspecific to subtypes. Research done on Tg, SPA, HIF1-α, and Alb have not displayed promising results for the diagnosis of traumatic deaths.
Despite none of the reviewed proteins here meeting the standard for postmortem
diagnostic biomarkers, due to either unassessed or low specificity and sensitivity, results and
observations should not be disregarded. Potential significance exists in the tandem use of
promising biomarkers following additional research to ensure significance towards cause of
death differentiation compared to postmortem changes, PMI, or to the agonal period.

Specifically, studies with stringent controls to verify the influence of these factors and
comparisons across the subtypes of traumatic deaths to ensure significance should be conducted.

Table 2: Complied results from reviewed studies related to trauma deaths. (+): significant
elevation, (-): no significant elevation or low expression, (+/-): results not significant to cause of
death.
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Discussion
Proteomic biomarkers have potential to be an additional tool for cause of death
determination in the field of forensic pathology. Due to the stability and direct reflective nature
of an organism’s physiological state, proteins are a good candidate for this route of study.
Analysis of postmortem protein expression offers a method that can assess the state of the body
at time of death, which can be significant in determining the cause of death. The validation of
proteomic biomarkers requires thorough work to ensure the proper specificity and sensitivity,
which has not yet been achieved. Potential biomarkers have been studied mainly in the
preliminary stages and none has yet been observed to be significant for one cause of death with
high enough specificity and detailed thresholds to be used reliably in cause of death

determination. The lack of a clear distinction between causes of death through a proteomic
perspective lends support to the use of multiple biomarkers in tandem to achieve a higher degree
of significance. A panel of biomarkers can potentially contribute to the differentiation process in
determining cause of death, following further studies to affirm significant correlation.
This literature review examined numerous studies conducted on postmortem protein
expression and potential correlation to cause of death determination across asphyxial,
toxicological, and traumatic deaths. Due to the novel nature of this reviewed intersection
between proteomics and forensic pathology, many of the reviewed studies were in the pilot
stages, across a small sample pool, or not yet validated and repeated to assess true accuracy.
Despite that, there is great value in the work done to identify postmortem protein expression
trends that lay the foundation for further research. This cohesive literature review outlines
significant findings, as well as complications, to promote future studies and proposes the use of a
panel of biomarkers in a postmortem application.
In assessing work done related to asphyxial death, the use of the protein S100B shows
promise. Specifically, the use of serum S100B offers to differentiate deaths due to strangulation
from deaths due to drowning and suffocation. The use of serum SP-D additionally offers promise
in determining deaths due to saltwater drowning when compared to strangulation and
suffocation. Through reviewing work done on postmortem protein analysis done on toxicological
deaths, the use of serum alkylated albumin-derived dipeptides, specifically C(-HETE)P, shows
promise for diagnosing deaths due to sulfur mustard exposure. In relation to trauma deaths, the
application of serum lactate dehydrogenase has shown good specificity in acute blunt force
trauma involving head injuries. A majority of the reviewed trauma studies have revealed more
potential significance through the analysis of CSF concentrations rather than serum

concentrations, which have been observed to be often correlated with the agonal period. In
researching fatalities due to blunt force head trauma, CSF concentrations of S100B, NSE, IL-6,
BDNF, and LDH display a high degree of observed significance, especially when considered in
tandem. While these findings show promise, it is essential that they are further studied across
multiple causes of death, determined to be insignificant to the agonal period or other postmortem
factors, and reliable thresholds are set before any biomarker can be used in a valid forensic
application.
In considering the potential application of postmortem biomarkers as a forensic
evidentiary tool, it is crucial to consider a lab’s practical capabilities. The introduction of novel
methodologies, after validation, can face difficulty in the implementation due to the requirement
of new lab instrumentation and additional training for personnel. Biomarkers considered for a
postmortem diagnostic panel should ideally be able to be sampled from serum or CSF, which can
be analyzed through equipment that may already be accessible in forensic labs, such as ELISA.
While IHC findings show promise in cause of death differentiation, accessibility might be
limited. It would be ideal that multiple methods of were used to validate an experimental result,
but this may not be feasible. However, specificity and stringency cannot be comprised, especially
due to the implicative nature of cause of death determination. Postmortem protein analysis stands
to be a powerful tool in aiding the determination of cause of death during medicolegal autopsies.
This literature review provides a complied source of significant findings, in which future studies
should expand on to determine the true source of significance for elevated postmortem protein
levels in order to develop reliable and valid methodologies.
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